Vasodilators in patients with chronic obstructive pulmonary disease and pulmonary hypertension: Not ready for prime time!

American Journal of Respiratory and Critical Care Medicine

Volumn 181, Issue 3, 2010, Pages 202-203

  Humbert, Marc ^a   Simonneau, Gérald ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ENDOTHELIN RECEPTOR AGONIST; PHOSPHODIESTERASE V INHIBITOR; PROSTACYCLIN DERIVATIVE; VASODILATOR AGENT;

ARTERIAL OXYGEN SATURATION; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL TRIAL; EDITORIAL; EXERCISE; EXERCISE TOLERANCE; GAS EXCHANGE; HUMAN; HYPOXIC LUNG VASOCONSTRICTION; LUNG HEMODYNAMICS; LUNG VENTILATION PERFUSION RATIO; PRIORITY JOURNAL; PULMONARY HYPERTENSION; SIDE EFFECT; VASODILATATION;

HUMANS; HYPERTENSION, PULMONARY; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; PULMONARY WEDGE PRESSURE; TREATMENT OUTCOME; VASOCONSTRICTION; VASODILATOR AGENTS;

EID: 76749096026     PISSN: 1073449X     EISSN: 15354970     Source Type: Journal    
DOI: 10.1164/rccm.200911-1723ED     Document Type: Editorial

References (14)

1. Simonneau G, Robbins IM, Beghetti M, Channick RN, Delcroix M, Denton CP, Elliott CG, Gaine SP, Gladwin MT, Jing ZC, et al. Updated clinical classification of pulmonary hypertension. J Am Coll Cardiol 2009;54:S43-S54.
2. Chaouat A, Bugnet AS, Kadaoui N, Schott R, Enache I, Ducoloné A, Ehrhart M, Kessler R, Weitzenblum E. Severe pulmonary hypertension and chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2005;172:189-194.
3. Chaouat A, Naeije R, Weitzenblum E. Pulmonary hypertension in COPD. Eur Respir J 2008;32:1371-1385.
4. Nathan SD, Noble PW, Tuder RM. Idiopathic pulmonary fibrosis and pulmonary hypertension: connecting the dots. Am J Respir Crit Care Med 2007;175:875-880.
5. Nunes H, Humbert M, Capron F, Brauner M, Sitbon O, Battesti JP, Simonneau G, Valeyre D. Pulmonary hypertension associated with sarcoidosis: mechanisms, haemodynamics and prognosis. Thorax 2006;61:68-74.
6. Fartoukh M, HumbertM, Capron F,Maître S, Parent F, Le Gall C, Sitbon O, Hervé P, Duroux P, Simonneau G. Severe pulmonary hypertension in histiocytosis X. Am J Respir Crit Care Med 2000;161:216-223.
7. Cottin V, Le Pavec J, Prévot G, Mal H, Humbert M, Simonneau G, Cordier J-F; GERMOP. Pulmonary hypertension in patients with combined pulmonary fibrosis and emphysema syndrome. Eur Respir J 2010;35:105-111.
8. Simonneau G, Escourrou P, Duroux P, Lockhart A. Inhibition of hypoxic pulmonary vasoconstriction by nifedipine. N Engl J Med 1981;304:1582-1585.
9. Humbert M, Sitbon O, Simonneau G. Treatment of pulmonary arterial hypertension. N Engl J Med 2004;351:1425-1436.
10. Blanco I, Gimeno E, Munoz PA, Pizarro S, Gistau C, Rodriguez-Roisin R, Roca J, Barberà JA. Hemodynamic and gas exchange effects of sildenafil in patients with chronic obstructive pulmonary disease and pulmonary hypertension. Am J Respir Crit Care Med 2010;181:270-278.
11. Stolz D, Rasch H, Linka A, Di Valentino M, Meyer A, Brutsche M, Tamm M. A randomised, controlled trial of bosentan in severe COPD. Eur Respir J 2008;32:619-628.
12. Galiè N, Hoeper MM, Humbert M, Torbicki A, Vachiery J-L, Barbera JA, Beghetti M, Corris P, Gaine S, Gibbs JS, et al. Guidelines for the diagnosis and treatment of pulmonary hypertension: The Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS), endorsed by the International Society of Heart and Lung Transplantation (ISHLT). Eur Heart J 2009;30:2493-2537.
13. Galiè N, Hoeper MM, Humbert M, Torbicki A, Vachiery JL, Barberà JA, Beghetti M, Corris P, Gaine S, Gibbs JS, et al.; Task Force for Diagnosis and Treatment of Pulmonary Hypertension of European Society of Cardiology (ESC). European Respiratory Society (ERS); International Society of Heart and Lung Transplantation (ISHLT). Guidelines for the diagnosis and treatment of pulmonary hypertension. Eur Respir J 2009;34:1219-1263.
14. Roger N, Barberà JA, Roca J, Rovira I, Gómez FP, Rodriguez-Roisin R. Nitric oxide inhalation during exercise in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1997;156:800-806.